Regulatory approval of islet transplantation for treatment of type 1 diabetes: Implications and what is on the horizon.
作者信息
Stabler Cherie L, Russ Holger A
机构信息
J. Crayton Pruitt Family Department of Biomedical Engineering, Herbert Wertheim College of Engineering, University of Florida, Gainesville, FL 32611, USA; Diabetes Institute, University of Florida, Gainesville, FL 32610, USA.
Department of Pharmacology and Therapeutics, College of Medicine, University of Florida, Gainesville, FL 32610, USA; Diabetes Institute, University of Florida, Gainesville, FL 32610, USA.
出版信息
Mol Ther. 2023 Nov 1;31(11):3107-3108. doi: 10.1016/j.ymthe.2023.10.011. Epub 2023 Oct 20.
Abstract
摘要
相似文献
1
Regulatory approval of islet transplantation for treatment of type 1 diabetes: Implications and what is on the horizon.胰岛移植治疗1型糖尿病的监管批准：影响及未来展望。
Mol Ther. 2023 Nov 1;31(11):3107-3108. doi: 10.1016/j.ymthe.2023.10.011. Epub 2023 Oct 20.
2
Considerations and challenges of islet transplantation and future therapies on the horizon.胰岛移植的考量与挑战以及即将出现的未来疗法。
Am J Physiol Endocrinol Metab. 2022 Feb 1;322(2):E109-E117. doi: 10.1152/ajpendo.00310.2021. Epub 2021 Dec 20.
3
[Transplantation of the islets of Langerhans in patients with diabetes mellitus type 1].1型糖尿病患者胰岛移植
Ned Tijdschr Geneeskd. 2005 Jan 1;149(1):12-6.
4
Advancements in transplantation therapy for diabetes: Pancreas, islet and stem cell.糖尿病移植治疗的进展：胰腺、胰岛和干细胞。
J Diabetes Investig. 2021 Feb;12(2):143-145. doi: 10.1111/jdi.13358. Epub 2020 Aug 27.
5
Update on islet-cell transplantation for type 1 diabetes.1型糖尿病胰岛细胞移植的最新进展
Lancet. 2002 Jun 22;359(9324):2172. doi: 10.1016/s0140-6736(02)09187-0.
6
Hydrogel materials for the application of islet transplantation.水凝胶材料在胰岛移植中的应用。
J Biomater Appl. 2019 Apr;33(9):1252-1264. doi: 10.1177/0885328219831391. Epub 2019 Feb 21.
7
Using Mesenchymal Stromal Cells in Islet Transplantation.应用间充质基质细胞进行胰岛移植。
Stem Cells Transl Med. 2018 Aug;7(8):559-563. doi: 10.1002/sctm.18-0033. Epub 2018 May 11.
8
Insulin independence by supplemental islet transplantation 5 years after initial islet transplantation.初次胰岛移植5年后通过补充胰岛移植实现胰岛素非依赖。
J Diabetes. 2011 Dec;3(4):353-5. doi: 10.1111/j.1753-0407.2011.00146.x.
9
Could islet transplantation be a potential cure for diabetes?胰岛移植能否成为糖尿病的一种潜在治愈方法？
Nurs Times. 2003;99(15):48-9.
10
FDA regulation of allogeneic islets as a biological product.美国食品药品监督管理局对作为生物制品的同种异体胰岛的监管。
Cell Biochem Biophys. 2004;40(3 Suppl):19-22. doi: 10.1385/cbb:40:3:19.
引用本文的文献
1
Neuroendocrine cells orchestrate regeneration through Desert hedgehog signaling.神经内分泌细胞通过沙漠刺猬信号通路协调再生过程。
Cell. 2025 Jun 3. doi: 10.1016/j.cell.2025.05.012.
2
Single-cell genomics and spatial transcriptomics in islet transplantation for diabetes treatment: advancing towards personalized therapies.用于糖尿病治疗的胰岛移植中的单细胞基因组学和空间转录组学：迈向个性化疗法
Front Immunol. 2025 Feb 20;16:1554876. doi: 10.3389/fimmu.2025.1554876. eCollection 2025.
3
Current status of pancreatic islet xenotransplantation.胰岛异种移植的现状
Clin Transplant Res. 2025 Mar 31;39(1):1-11. doi: 10.4285/ctr.24.0046. Epub 2025 Feb 10.
4
Islet Cell Replacement and Regeneration for Type 1 Diabetes: Current Developments and Future Prospects.1型糖尿病的胰岛细胞替代与再生：当前进展与未来展望
BioDrugs. 2025 Mar;39(2):261-280. doi: 10.1007/s40259-025-00703-7. Epub 2025 Feb 7.
5
Clinical Islet Xenotransplantation: Development of Isolation Protocol, Anti-Rejection Strategies, and Clinical Outcomes.临床胰岛异种移植：分离方案的开发、抗排斥策略和临床结果。
Cells. 2024 May 13;13(10):828. doi: 10.3390/cells13100828.
本文引用的文献
1
Developments in stem cell-derived islet replacement therapy for treating type 1 diabetes.干细胞衍生胰岛替代治疗 1 型糖尿病的研究进展。
Cell Stem Cell. 2023 May 4;30(5):530-548. doi: 10.1016/j.stem.2023.04.002.
2
Long-term Outcomes With Islet-Alone and Islet-After-Kidney Transplantation for Type 1 Diabetes in the Clinical Islet Transplantation Consortium: The CIT-08 Study.临床胰岛移植联盟中1型糖尿病单独胰岛移植和肾后胰岛移植的长期结果：CIT-08研究
Diabetes Care. 2022 Oct 17;45(12):2967-75. doi: 10.2337/dc21-2688.
3
A Worldwide Survey of Activities and Practices in Clinical Islet of Langerhans Transplantation.一项关于临床胰岛移植活动与实践的全球调查。
Transpl Int. 2022 Aug 11;35:10507. doi: 10.3389/ti.2022.10507. eCollection 2022.
4
Islet cell transplantation hits a milestone.胰岛细胞移植取得了一个里程碑式的成果。
Am J Transplant. 2021 Aug;21(8):2625-2626. doi: 10.1111/ajt.16039.
5
Strategies for durable β cell replacement in type 1 diabetes.1 型糖尿病中β细胞持久替代的策略。
Science. 2021 Jul 30;373(6554):516-522. doi: 10.1126/science.abh1657.
6
Regulatory updates are needed to prevent the commercialization of islet transplantation in the United States.需要进行监管更新，以防止胰岛移植在美国商业化。
Am J Transplant. 2021 Jul;21(7):2620-2622. doi: 10.1111/ajt.16555. Epub 2021 Mar 20.
7
The demise of islet allotransplantation in the United States: A call for an urgent regulatory update.美国胰岛同种异体移植的衰落：呼吁紧急更新监管规定。
Am J Transplant. 2021 Apr;21(4):1365-1375. doi: 10.1111/ajt.16397. Epub 2021 Feb 10.
8
Solving the Puzzle of Immune Tolerance for β-Cell Replacement Therapy for Type 1 Diabetes.解决 1 型糖尿病β细胞替代治疗中免疫耐受问题。
Cell Stem Cell. 2020 Oct 1;27(4):505-507. doi: 10.1016/j.stem.2020.09.008.
9
Engineering immunomodulatory biomaterials for type 1 diabetes.用于1型糖尿病的工程免疫调节生物材料
Nat Rev Mater. 2019 Jun;4(6):429-450. doi: 10.1038/s41578-019-0112-5. Epub 2019 May 17.
10
Regulatory Framework for Advanced Therapy Medicinal Products in Europe and United States.欧美先进治疗药品监管框架
Front Pharmacol. 2019 Aug 30;10:921. doi: 10.3389/fphar.2019.00921. eCollection 2019.
Zotero 插件